+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)
This field is for validation purposes and should be left unchanged.

Archives

Loading Events

Updates in IgA Nephropathy

Thank you for attending, we hope you enjoyed this webinar.

Please tell us what you thought about today’s presentation by taking the survey below:

Updates in IgA Nephropathy

Learn the latest advancements in the understanding and management of IgA Nephropathy (IgAN) with two expert-led videos sponsored by Otsuka with Professors Brad Rovin, MD (United States) and Jürgen Floege, MD (Germany). In these videos, Dr. Rovin and Dr. Floege share their perspectives on cutting-edge research, innovative therapies, and the practical implications for improving outcomes for people with IgAN.

Dr. Rovin and Dr. Floege are currently co-chairing the forthcoming KDIGO 2025 IgA Nephropathy/IgA Vasculitis and Nephrotic Syndrome in Children Guidelines. They have also co-chaired the 2024 Lupus Nephritis and ANCA Vasculitis Guidelines and the 2021 Glomerular Diseases Guideline.

These videos, recorded by KDIGO and sponsored by Otsuka in October 2024 in San Diego, California, offer valuable insights for healthcare professionals looking to stay informed on this rapidly evolving area of kidney care.

Updates in IgA Nephropathy – Part 1 with Dr. Brad Rovin

In this insightful video, Brad Rovin, MD (United States) discusses the latest updates in IgA nephropathy, focusing on advances in diagnosis, treatment, and patient care. Dr. Rovin highlights the evolving role of novel therapies, biomarkers, and patient-centered approaches in managing this complex kidney disease. Dr. Rovin’s expert perspective offers invaluable guidance for clinicians navigating this rapidly changing field.

Updates in IgA Nephropathy – Part 2 with Dr. Jürgen Floege

In this informative video, Jürgen Floege, MD (Germany) delves into the latest updates in IgA Nephropathy (IgAN), highlighting advancements in treatment strategies, emerging therapies, the role of prediction tools in disease prognosis, and the practical integration of research into clinical care. Dr. Floege addresses the challenges of global implementation, emphasizing how resource and cost constraints in some countries impact access to new therapies and explores strategies to optimize the use of older therapies to overcome these barriers. He also underscores the importance of early intervention and personalized, patient-centered approaches to managing IgAN. Dr. Floege’s expert insights offer invaluable guidance for clinicians navigating this complex kidney disease.

For additional information the DRAFT Guidelines or additional KDIGO resources : https://kdigo.org/events/updates-in-iga-nephropathy-2024/

References:

  1. Updates in IgA Nephropathy – KDIGO.” Kdigo.org, 2024, org/events/updates-in-iga-nephropathy-2024/ Accessed 12 Nov. 2024

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

December 2024    US.CORP.X.24.00340

Registration

Please Log In Or Join to Register for this Event.

Related Resources

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.